LITS 10-Q Quarterly Report Dec. 31, 2021 | Alphaminr

LITS 10-Q Quarter ended Dec. 31, 2021

MEI PHARMA, INC.
10-Ks and 10-Qs
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
CIK: 1262104
Filing Type: 10-Q/A
Report Date: 2021-12-31
Download URL: https://www.sec.gov/Archives/edgar/data/1262104/000095017022010495/meip-20211231.htm
]]>
TABLE OF CONTENTS
Part I Financial InformationItem 1: Condensed Financial Statements UnauditedNote 1. The Company and Summary Of Significant Accounting PoliciesNote 2. Fair Value MeasurementsNote 3. License AgreementsNote 4. Beigene CollaborationNote 5. Net Loss Per ShareNote 6. Commitments and ContingenciesNote 7. LeasesNote 8. Short-term InvestmentsNote 9. Stockholders EquityNote 10. Share-based CompensationItem 2: Management S Discussion and Analysis Of Financial Condition and Results Of OperationsItem 3: Quantitative and Qualitative Disclosures About Market RiskItem 4: Controls and ProceduresPart II Other InformationItem 1: Legal ProceedingsItem 1A: Risk FactorsItem 2: Unregistered Sales Of Equity Securities and Use Of ProceedsItem 3: Defaults Upon Senior SecuritiesItem 4: Mine Safety DisclosuresItem 5: Other InformationItem 6: Exhibits

Exhibits

3.1 Fourth Amended and Restated By-Laws of MEI Pharma, Inc., effective as of December 16, 2021, (incorporated by reference to Exhibit 3.1 to the Registrants Current Report on Form 8-K filed on December 17, 2021 (File No 000-50484)). 10.1 Transition and Retirement Agreement between Brian G. Drazba and MEI Pharma, Inc., dated as of December 21, 2021. (incorporated by reference to Exhibit 10.1 to the Registrants Current Report on Form 8-K filed on December 23, 2021 (File No. 000-50484)). 31.1 Rule 13a-14(a) or Rule 15d-14(a) Certification of Principal Executive Officer. 31.2 Rule 13a-14(a) or Rule 15d-14(a) Certification of Principal Financial Officer. 32.1 Certification of Principal Executive Officer and Principal Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C 1350).